“Your analysis of our potential reimbursement options is the only consultant report I’ve ever received that REALLY helped me.”
            - Director of a medical device company, preparing for product launch

“Our clients and our sales staff have benefited tremendously by your reimbursement contact center. It runs perfectly!”
            - National sales manager at a large device manufacturer

“We were facing some difficult payment issues – but your work was particularly helpful in pushing us through.”
           - CEO of a start-up medical device company

“Thanks to your comprehensive, coherent scenario analysis, we’ve been empowered to move forward with a viable decision, despite very complicated circumstances.”
           - Head of a physician specialty group that adopted new technology

“We greatly value your work in outlining our legislative and regulatory recourse options. Without your advice, we wouldn’t have been able to make a good decision.”
           - CEO of device company seeking to rectify Medicare payment problems

“We were very impressed with your astute reimbursement strategies for a medical device company in our portfolio.”
            - Partner at a Venture Capital firm

“The JR Associates staff is extremely knowledgeable. It’s refreshing to see how enthusiastically you share your insights.”
            - Clinic manager whose department was trained by our team

“Reimbursement is often one of the most challenging steps to successful U.S. market entry. For us, your strategic planning and timely tactical advice guided us in making tough choices. You brought-in appropriate outside payer representatives to validate you suggestions. Your team was there to help us in our planning efforts and to assist us in defining unmet market needs for our product. I highly recommend JR Associates for any international medical device start-up that is seeking U.S. reimbursement.”
           - President, foreign-based medical device company

“Your facilitation of reimbursement support services has made all the difference in the world to our young company.”
            - Clinical director of a device venture